An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England

Katherine M E Turner, Jeff A Round, Paddy J Horner, John A A Macleod, Simon Goldenberg, Arminder Deol, Elisabeth J Adams

Research output: Contribution to journalArticle (Academic Journal)peer-review

53 Citations (Scopus)

Abstract

To estimate the costs and benefits of clinical pathways incorporating a point of care (POC) nucleic acid amplification test (NAAT) for chlamydia and gonorrhoea in genitourinary medicine (GUM) clinics compared with standard off-site laboratory testing.
Original languageEnglish
Pages (from-to)104-111
Number of pages8
JournalSexually Transmitted Infections
Volume90
Issue number2
DOIs
Publication statusE-pub ahead of print - 22 Nov 2013

Fingerprint

Dive into the research topics of 'An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England'. Together they form a unique fingerprint.

Cite this